The effects of ECT on brain glucose: a pilot FDG PET study

Area of Science:

• Neuroscience
• Radiology
• Psychiatry

Background:

• Electroconvulsive therapy (ECT) is a treatment for major depression.
• Brain activity changes after ECT are not fully understood.
• Positron emission tomography (PET) with [18F]-fluorodeoxyglucose (FDG) can measure brain glucose metabolism.

Purpose of the Study:

• To investigate regional brain glucose metabolism changes following ECT in patients with major depression.
• To correlate metabolic changes with clinical outcomes.

Main Methods:

• Six patients with major depression underwent FDG-PET scans before and after bifrontotemporal ECT.
• Patients were medication-free for at least two weeks prior to scanning.
• Region of interest (ROI) analysis was used to assess absolute and normalized metabolic rates.

Main Results:

• A significant decrease in absolute cerebral metabolic rate for glucose (CMRglu) was observed in 17 out of 61 brain regions post-ECT.
• Decreases in CMRglu in the right parietal and frontal lobes correlated significantly with reduced Hamilton Depression Rating Scale (HDRS) scores.
• Normalized CMRglu showed significant increases in specific regions, including the basal ganglia and upper brainstem.

Conclusions:

• ECT reduces global brain glucose metabolism, consistent with prior studies.
• Frontal lobe metabolic changes correlate with clinical improvement in depression.
• Novel findings include relative increases in CMRglu in dopaminergic regions like the caudate and upper brainstem.